We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
45 hedge funds and large institutions have $267M invested in Corvus Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 10
13% more capital invested
Capital invested by funds: $237M → $267M (+$30.3M)
0% more funds holding
Funds holding: 45 → 45 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
Holders
45
Holders Change
–
Holders Change %
0%
% of All Funds
1.2%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
7
Increased
15
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$2.79M |
| 2 |
Millennium Management
New York
|
+$1.59M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$771K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$532K |
| 5 |
State Street
Boston,
Massachusetts
|
+$368K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$18.5M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.86M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$285K |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$184K |
| 5 |
JP Morgan Chase
New York
|
-$147K |
